Last reviewed · How we verify
salvianolate injection
Salvianolate is a water-soluble extract from Salvia miltiorrhiza that improves microcirculation and reduces blood viscosity by inhibiting platelet aggregation and promoting fibrinolysis.
Salvianolate is a water-soluble extract from Salvia miltiorrhiza that improves microcirculation and reduces blood viscosity by inhibiting platelet aggregation and promoting fibrinolysis. Used for Acute ischemic stroke, Unstable angina pectoris, Myocardial infarction.
At a glance
| Generic name | salvianolate injection |
|---|---|
| Also known as | Salvianolate |
| Sponsor | Green Valley Group of China |
| Drug class | Herbal extract / antiplatelet agent |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular / Cerebrovascular |
| Phase | FDA-approved |
Mechanism of action
Salvianolate contains multiple active compounds (salvianolic acids) that work through antiplatelet and anticoagulant mechanisms to enhance blood flow and reduce thrombotic events. It is believed to act on multiple pathways including inhibition of thromboxane synthesis and enhancement of prostacyclin, thereby improving tissue perfusion and reducing ischemic injury in cardiovascular and cerebrovascular conditions.
Approved indications
- Acute ischemic stroke
- Unstable angina pectoris
- Myocardial infarction
Common side effects
- Bleeding or hemorrhage
- Gastrointestinal discomfort
- Headache
Key clinical trials
- Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin (NA)
- Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI (PHASE4)
- Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris (PHASE4)
- Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- salvianolate injection CI brief — competitive landscape report
- salvianolate injection updates RSS · CI watch RSS
- Green Valley Group of China portfolio CI